Aspira Women's Health Inc.

AWHLSEC EDGAR

In Vitro & In Vivo Diagnostic Substances(DE)CIK: 926617

Revenue (Latest FY)

$9.2M

Net Income (Latest FY)

-$16.7M

Industry

In Vitro & In Vivo Diagnostic Substances

Recent Filings

Company Details

CIK926617

Fiscal Year End1231

CategoryNon-accelerated filer<br>Smaller reporting company

StateDE

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)